Genotyping and phenotyping cytochrome P450 : Perspectives for cancer treatmentMATHIJSSEN, Ron H. J; VAN SCHAIK, Ron H. N.European journal of cancer (1990). 2006, Vol 42, Num 2, pp 141-148, issn 0959-8049, 8 p.Article

Genetic Techniques for Pharmacogenetic AnalysesVAN DER STRAATEN, Tahar; VAN SCHAIK, Ron H. N.Current pharmaceutical design (Print). 2010, Vol 16, Num 2, pp 231-237, issn 1381-6128, 7 p.Article

Association Between Genetic Variation in the ABCB1 Gene and Switching, Discontinuation, and Dosage of Antidepressant Therapy: Results From the Rotterdam StudyNOORDAM, Raymond; AARTS, Nikkie; HOFMAN, Albert et al.Journal of clinical psychopharmacology. 2013, Vol 33, Num 4, pp 546-550, issn 0271-0749, 5 p.Article

CYP3A5 Genotype Is Not Related to the Intrapatient Variability of Tacrolimus ClearancePASHAEE, Nilufar; BOUAMAR, Rachida; HESSELINK, Dennis A et al.Therapeutic drug monitoring. 2011, Vol 33, Num 3, pp 369-371, issn 0163-4356, 3 p.Article

UGT2B7 promoter variant -840G>A contributes to the variability in hepatic clearance of morphine in patients with sickle cell diseaseDARBARI, Deepika S; VAN SCHAIK, Ron H. N; CAPPARELLI, Edmund V et al.American journal of hematology. 2008, Vol 83, Num 3, pp 200-202, issn 0361-8609, 3 p.Article

CYP3As variant allele frequencies in Dutch CaucasiansVAN SCHAIK, Ron H. N; VAN DER HEIDEN, Ilse P; VAN DEN ANKER, John N et al.Clinical chemistry (Baltimore, Md.). 2002, Vol 48, Num 10, pp 1668-1671, issn 0009-9147, 4 p.Article

Interaction between polymorphisms in the OCT1 and MATE1 transporter and metformin responseBECKER, Matthijs L; VISSER, Loes E; VAN SCHAIK, Ron H. N et al.Pharmacogenetics and genomics (Print). 2010, Vol 20, Num 1, pp 38-44, issn 1744-6872, 7 p.Article

OCT1 polymorphism is associated with response and survival time in anti-Parkinsonian drug usersBECKER, Matthijs L; VISSER, Loes E; VAN SCHAIK, Ron H. N et al.Neurogenetics (Oxford. Print). 2011, Vol 12, Num 1, pp 79-82, issn 1364-6745, 4 p.Article

Influence of ketoconazole on the fecal and urinary disposition of docetaxelENGELS, Frederike K; LOOS, Walter J; MATHOT, Ron A. A et al.Cancer chemotherapy and pharmacology. 2007, Vol 60, Num 4, pp 569-579, issn 0344-5704, 11 p.Article

Genetic Variation in the Multidrug and Toxin Extrusion 1 Transporter Protein Influences the Glucose-Lowering Effect of Metformin in Patients With Diabetes : A Preliminary StudyBECKER, Matthijs L; VISSER, Loes E; VAN SCHAIK, Ron H. N et al.Diabetes (New York, NY). 2009, Vol 58, Num 3, pp 745-749, issn 0012-1797, 5 p.Article

The Role of Pharmacogenetics in the Disposition of and Response to Tacrolimus in Solid Organ TransplantationHESSELINK, Dennis A; BOUAMAR, Rachida; ELENS, Laure et al.Clinical pharmacokinetics. 2014, Vol 53, Num 2, pp 123-139, issn 0312-5963, 17 p.Article

A new CYP3A5 variant, CYP3A5*11, is shown to be defective in nifedipine metabolism in a recombinant cDNA expression systemLEE, Su-Jun; VAN DER HEIDEN, Ilse P; GOLDSTEIN, Joyce A et al.Drug metabolism and disposition. 2007, Vol 35, Num 1, pp 67-71, issn 0090-9556, 5 p.Article

Efavirenz dose reduction to 200 mg once daily in a patient treated with rifampicinVAN LUIN, Matthijs; BROUWER, Anne-Marie; VAN DER VEN, Andre et al.AIDS (London). 2009, Vol 23, Num 6, pp 742-744, issn 0269-9370, 3 p.Article

The CYP3A4^*3 Allele: Is it really rare?VAN SCHAIK, Ron H. N; DE WILDT, Saskia N; BROSENS, Rebecca et al.Clinical chemistry (Baltimore, Md.). 2001, Vol 47, Num 6, pp 1104-1106, issn 0009-9147Article

Prostate-Specific Antigen (PSA) Isoform p2PSA in Combination with Total PSA and Free PSA Improves Diagnostic Accuracy in Prostate Cancer DetectionJANSEN, Flip H; VAN SCHAIK, Ron H. N; KURSTJENS, Joep et al.European urology. 2010, Vol 57, Num 6, pp 921-927, issn 0302-2838, 7 p.Article

Interpatient variability in IMPDH activity in MMF-treated renal transplant patients is correlated with IMPDH type II 3757T>C polymorphismSOMBOGAARD, Ferdi; VAN SCHAIK, Ron H. N; MATHOT, Ron A et al.Pharmacogenetics and genomics (Print). 2009, Vol 19, Num 8, pp 626-634, issn 1744-6872, 9 p.Article

The risk of myocardial infarction in patients with reduced activity of cytochrome P450 2C9VISSER, Loes E; VAN SCHAIK, Ron H. N; JAN DANSER, Alexander H et al.Pharmacogenetics and genomics (Print). 2007, Vol 17, Num 7, pp 473-479, issn 1744-6872, 7 p.Article

The risk of bleeding complications in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumonVISSER, Loes E; VAN SCHAIK, Ron H. N; VAN VLIET, Martin et al.Thrombosis and haemostasis. 2004, Vol 92, Num 1, pp 61-66, issn 0340-6245, 6 p.Article

ABCB1 and ABCC3 Gene Polymorphisms Are Associated with First-year Response to Methotrexate in Juvenile Idiopathic ArthritisDE ROTTE, Maurits C. F. J; BULATOVIC, Maja; HEIJSTEK, Marloes W et al.Journal of rheumatology. 2012, Vol 39, Num 10, pp 2032-2040, issn 0315-162X, 9 p.Article

The interactions of age, genetics, and disease severity on tacrolimus dosing requirements after pediatric kidney and liver transplantationDE WILDT, Saskia N; VAN SCHAIK, Ron H. N; SOLDIN, Offie P et al.European journal of clinical pharmacology. 2011, Vol 67, Num 12, pp 1231-1241, issn 0031-6970, 11 p.Article

Cytochrome P450 3A gene variation, steroid hormone serum levels and prostate cancer——The Rotterdam StudySIEMES, Claire; VISSER, Loes E; DE JONG, Frank H et al.Steroids. 2010, Vol 75, Num 12, pp 1024-1032, issn 0039-128X, 9 p.Article

Postmenstrual Age and CYP2D6 Polymorphisms Determine Tramadol O-demethylation in Critically III Neonates and InfantsALLEGAERT, Karel; VAN SCHAIK, Ron H. N; VERMEERSCH, Steve et al.Pediatric research. 2008, Vol 63, Num 6, pp 674-679, issn 0031-3998, 6 p.Article

Effects of the renin-angiotensin system genes and salt sensitivity genes on blood pressure and atherosclerosis in the total population and patients with type 2 diabetesYAZDANPANAH, Mojgan; AULCHENKO, Yuri S; LAMBERTS, Steven W. J et al.Diabetes (New York, NY). 2007, Vol 56, Num 7, pp 1905-1912, issn 0012-1797, 8 p.Article

Allelic variants of cytochrome P450 2C9 modify the interaction between nonsteroidal anti-inflammatory drugs and coumarin anticoagulantsVISSER, Loes E; VAN SCHAIK, Ron H. N; VAN VLIET, Martin et al.Clinical pharmacology and therapeutics. 2005, Vol 77, Num 6, pp 479-485, issn 0009-9236, 7 p.Article

Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the MDR-1, CYP3A4, and CYP3A5 genesHESSELINK, Dennis A; VAN GELDER, Teun; VAN SCHAIK, Ron H. N et al.Clinical pharmacology and therapeutics. 2004, Vol 76, Num 6, pp 545-556, issn 0009-9236, 12 p.Article